|Bid||86.80 x 300|
|Ask||87.49 x 100|
|Day's Range||87.33 - 87.54|
|52 Week Range||51.16 - 87.86|
|PE Ratio (TTM)||38.40|
|Earnings Date||Aug 1, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||86.96|
PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.
PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard™ employer.
NEW YORK , July 3, 2017 /PRNewswire/ -- ARI Network Services, Inc. (ARIS) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed ...